NCT04706325

Brief Summary

In this study, we investigate whether the early detection of risk factors in Covid-19 associated acute kidney injury contributes to us in the early initiation of treatment. We predict that if acute kidney damage is detected early in patients with early risk factors, permanent kidney damage will be seen less. In addition, we think that covid-19 patients may have positive contributions to shortening treatment time and reducing treatment costs. In addition, we are investigating whether it has a positive effect on patients' survival. In other words, we are investigating the contribution of risk factors to early diagnosis and treatment, the effect on health expenditures and mortality in patients with COVID-19 with acute kidney damage.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2021

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

January 11, 2021

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 12, 2021

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2021

Completed
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2021

Completed
Last Updated

January 12, 2021

Status Verified

January 1, 2021

Enrollment Period

4 months

First QC Date

January 11, 2021

Last Update Submit

January 11, 2021

Conditions

Acute Kidney Injury

Outcome Measures

Primary Outcomes (1)

  • KDIGO

    Kidney Disease: Improving Global Outcomes

    4 MONTHS

Study Arms (3)

COVİD19 PCR (Polymerase Chain Reaction) AND CT POSITIVE

COVİD19 PCR (Polymerase Chain Reaction) AND CT POSITIVE

Other: ACUTE KIDNEY INJURY

COVİD19 PCR (Polymerase Chain Reaction)NEGATİVE AND CT POSITIVE

COVİD19 PCR (Polymerase Chain Reaction)NEGATİVE AND CT POSITIVE

Other: ACUTE KIDNEY INJURY

COVİD19 PCR (Polymerase Chain Reaction) AND CT will be evaluated as NEGATIVE.

COVİD19 PCR (Polymerase Chain Reaction) AND CT will be evaluated as NEGATIVE.

Other: ACUTE KIDNEY INJURY

Interventions

ACUTE KIDNEY INJURYOTHER

KDIGO LEVELS

COVİD19 PCR (Polymerase Chain Reaction) AND CT POSITIVECOVİD19 PCR (Polymerase Chain Reaction) AND CT will be evaluated as NEGATIVE.COVİD19 PCR (Polymerase Chain Reaction)NEGATİVE AND CT POSITIVE

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Over 18 aged * patients in ICU

You may qualify if:

  • Over 18 aged
  • patients in ICU

You may not qualify if:

  • Patients with known Chronic Renal Failure
  • who have received dialysis treatment before
  • who are under 18 years of age

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Akif Şahin

Kocaeli, Turkey (Türkiye)

RECRUITING

Related Publications (3)

  • Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, Li J, Yao Y, Ge S, Xu G. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020 May;97(5):829-838. doi: 10.1016/j.kint.2020.03.005. Epub 2020 Mar 20.

    PMID: 32247631RESULT

  • Aleebrahim-Dehkordi E, Reyhanian A, Saberianpour Sh, Hasanpour-Dehkordi A. Acute kidney injury in COVID-19; a review on current knowledge. J Nephropathol. 2020;9:e31. doi: 10.34172/jnp.2020.31

    RESULT

  • Alhazzani W, Moller MH, Arabi YM, Loeb M, Gong MN, Fan E, Oczkowski S, Levy MM, Derde L, Dzierba A, Du B, Aboodi M, Wunsch H, Cecconi M, Koh Y, Chertow DS, Maitland K, Alshamsi F, Belley-Cote E, Greco M, Laundy M, Morgan JS, Kesecioglu J, McGeer A, Mermel L, Mammen MJ, Alexander PE, Arrington A, Centofanti JE, Citerio G, Baw B, Memish ZA, Hammond N, Hayden FG, Evans L, Rhodes A. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med. 2020 May;46(5):854-887. doi: 10.1007/s00134-020-06022-5. Epub 2020 Mar 28.

    PMID: 32222812RESULT

MeSH Terms

Conditions

Acute Kidney Injury

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Officials

  • akif şahin

    kocaeli derh

    PRINCIPAL INVESTIGATOR

Central Study Contacts

mehmet yılmaz

CONTACT

05052174432drmyilmaz33@gmail.com

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
md

Study Record Dates

First Submitted

January 11, 2021

First Posted

January 12, 2021

Study Start

January 1, 2021

Primary Completion

May 1, 2021

Study Completion

May 15, 2021

Last Updated

January 12, 2021

Record last verified: 2021-01

Data Sharing

IPD Sharing
Will not share

Locations

TU(1)